biomedicina slovenica


pr=Clausen : 37

  1. Hondebrink L.; Zammit M.; H L. C. G.; Hermanns-Clausen M.; Lonati D.; Faber K.; Brvar Miran
    Effect of the first wave of COVID-19 on Poison Control Centre activities in 21 European countries
    gbergc
    2022
  2. Stecher Nielsen Martine; Clausen Carolyn E.; Hirota Tomoya; Gregorič Kumperščak Hojka; Guerrero Anthony; Kaneko Hitoshi; Skokauskas Norbert
    A comparison of child and adolescent psychiatry in the Far East, Middle East, and Southeast Europe
    2022
  3. Gregorič Kumperščak Hojka; Clausen C.; Anagnostopoulos D.; Barac Otasevic Z.; Boricevic Marsanic V.; Burgic M.; Como A.; Nussbaum L.; Pejović-Milovančević Milica; Raleva M.
    Child and adolescent psychiatry training and mental health care in Southeast Europe
    2020
  4. Sandrini MP; Clausen AR; Munch-Petersen B; Piškur J
    Thymidine kinase diversity in bacteria
    2006
  5. Clausen AR; Matakos A; Sandrini MP; Piškur J
    Thymidine kinases in archaea
    2006
  6. Kosinska Urszula; Carnrot Cecilia; Sandrini Michael P; Clausen Anders R; Wang Liya; Piškur Jure; Eriksson Staffan; Eklund Hans
    Structural studies of thymidine kinases from Bacillus anthracis and Bacillus cereus provide insights into quaternary structure and conformational changes upon substrate binding
    2007
  7. Sandrini Michael P; Shannon Oonagh; Clausen Anders R; Bjorck Lars; Piškur Jure
    Deoxyribonucleoside kinases activate nucleoside antibiotics in severely pathogenic bacteria
    2007
  8. Sandrini Michael P; Clausen Anders R; On Stephen LW; Aarestrup Frank M; Munch-Petersen Birgitte; Piškur Jure
    Nucleoside analogues are activated by bacterial deoxyribonucleoside kinases in a species-specific manner
    2007
  9. Clausen Anders Ranegaard; Girandon Lenart; Knecht Wolfgang; Survery Sabeen; Andreasson Erik; Munch-Petersen BBirgitte; Piškur Jure
    A multisubstrate deoxyribonucleoside kinase from plants
    2008
  10. Massa C; Clausen MH; Stojan J; Lamba D; Campa C
    Study of the mode of action of a polygalacturonase from the phytopathogen Burkholderia cepacia
    2007
  11. Jenicke Lars; Klutmann Susanne; Bohuslavizki Karl H; Neuber Karsten; Altenhoff Juergen; Wedler Juliane; Buchert Ralph; Nebeling Bruno; Clausen Malte
    Conventional staging and 18F-FDG-PET staging of malignant melanoma
    [Določanje razširjenosti bolezni pri bolnikih z melanomom na konvenzionalni način ali z 18F-FDG-PET]
    2001
  12. Marschuetz MK; Clausen AE; Bernkop-Schnuerch A
    Development of a CMC-inhibitor conjugate protecting insulin from enzymatic attack in an artificial intestinal fluid
    1999
  13. Clausen AE; Marschuetz MK; Steininger S; Bernkop-Schnuerch A
    Method to control the stability of matrix tablets based on thiolated polycarbophil
    1999
  14. Clausen Helle V; Gundersen Hans JG; Larsen Lise G
    Stereological estimation of tubular length from thin vertical sections
    2000
  15. Klutmann Susanne; Bohuslavizki Karl H; Kroeger Sabine; Jenicke Lars; Buchert Ralph; Mester Janos; Clausen Malte
    Bone marrow protection by amifostine in Re-186-HEDP treatment: first results obtained in a rabbit animal model
    [Zaščita kostnega mozga z amifostinom pri zdravljenju z Re-186-HEDP: pri rezultati na živalskem modelu]
    2000
  16. Bohuslavizki Karl H; Klutmann Susanne; Bruns Juergen; Kroeger Sabine; Bleckmann Christian; Buchert Ralph; Dobrowolskij Dimitrij; Mester Janos; Clausen Malte
    Value of 18F-FDG-PET in clinical management of patients with osteosarcoma
    [Pomen 18F-FDG-PET pri vodenju bolnikov z osteosarkomom]
    2000
  17. Bohuslavizki Karl H; Klutmann Susanne; Neuber Karsten; Wedler Juliane; Altenhoff Juergen; Kroeger Sabine; Buchert Ralph; Bleckmann Christian; Clausen Malte
    Correlation of 18F-FDG-PET and histopathology in patients with malignant melanoma
    [Korelacija 18F-FDG-PET s histopatologijo pri bolnikih z malignim melanomom]
    2000
  18. Bohuslavizki Karl H; Klutmann Susane; Buchert Ralph; Kroeger Sabine; Werner Jochen A; Mester Janos; Clausen Malte
    Value of F-18-FDG PET in patients with cervical lymph node metastases of unknown origin
    [Pomen preiskave s F-18-FDG PET pri bolnikih z mestazami v vratnih bezgavkah neznanega izvora]
    1999
  19. Klutmann Susanne; Bohuslavizki Karl H; Brenner Winfried; Kroeger Sabine; Bleckmann Christian; Mester Janos; Henze Eberhard; Clausen Malte
    Positron emission tomography (PET) in clinical routine
    [Pozitronska emisijska tomografija (PET) v klinični praksi]
    1999
  20. Bohuslavizki Karl H; Buchert Ralph; Mester Janos; Clausen Malte
    Standardized image documentation in nuclear medicine
    [Standardizirana slikovna dokumentacija v nuklearni medicini]
    1999
  21. Klutmann Susanne; Bohuslavizki Karl H; Schulte Ulrike; Kroeger Sabine; Bleckmann Christian; Mester Janos; Clausen Malte
    Palliation of painful osseous metastases in patients with prostate cancer using Re-186-HEDP
    [Paliativno zdravljenje bolečih kostnih metastaz pri bolnikih s karcinomom prostate z uporabo Re-186-HEDP]
    1998
  22. Master Janos; Bohuslavizki Karl H; Klutmann Susanne; Sera Terez; Buchert Ralph; Pavics Laszlo; Henze Eberhard; Clausen Malte
    Recent developments in nuclear medicine instrumentation
    [Novosti o opremi v nuklearni medicini]
    1998
  23. Huebner Ralf-Harto; Bohuslavizki Karl H; Brenner Winfried; Klutmann Susanne; Feyerabend Bernd; Luettges Jutta; Tinnemeyer Stephan; Mester Janos; Clausen Malte; Henze Eberhard
    Radioprotection of salivary glands by amifostine in high-dose radioiodine therapy investigated in a new rabbit animal model
    1997
  24. Bohuslavizki Karl H; Mester Janos; Brenner Winfried; Buchert Ralf; Klutmann Susanne; Clausen Malte; Henze Eberhard
    Value of scintigraphic imaging in the detection of pancreatic tumors - the role of FDG-PET
    1997
  25. Bohuslavizki Karl H; Brenner Winfried; Tinnemeyer Stephan; Lassmann Stefan; Kalina Sonia; Mester Janos; Clausen Malte; Henze Eberhard
    Is quantitative salivary gland scintigraphy a mandatory examination prior to and after radioiodine therapy?
    1997
  26. Bohuslavizki Karl H; Brenner Winfried; Clausen Malte; Henze Eberhard
    Positron emission tomography (PET) in ischemic heart disease
    1996
  27. Wolf Heike; Brenner Winfried; Stein Volker; Tinnemeyer Stephan; Bohuslavizki Karl H; Teichert Ulrich; Clausen Malte; Henze Eberhard
    Insulin dependency of F-18-fluorodeoxyglucose accumulation in breast carcinoma cells compared to TI-201 uptake
    1996
  28. Bohuslavizki Karl Heinz; Brenner Winfried; Tinnemeyer Stephan; Felber Matthias; Clausen Malte; Henze Eberhard
    Scatter correction in hippuran clearance estimation with the modified Oberhausen tecnique
    1996
  29. Brenner Winfried; Wolf Heike; Bohuslavizki Karl H; Erdmann Karen; Koening Markus; Stauch Catherina; Clausen Malte; Henze Eberhard
    Effects of verapamil on cardiac uptake of radiolabeled doxorubicin and iodo-doxorubicin in rabbits
    1996
  30. Bohuslavizki KH; Brenner W; Tinnemeyer S; Wolf H; Sippel C; Toenshoff G; Karde P; Stauch C; Clausen M; Henze E
    Normal data base for quantitative salivary gland scintigraphy
    1995
  31. Bohuslavizki Karl H; Wolf Heike; Kutzner Doris; Brenner Winfried; Tinnemeyer Stephan; Sippel Christian; Clausen Malte; Henze Eberhard
    Uptake kinetics of radiolabelled 1,8-dihydroxyanthraquinone and acridinone derivatives in cultures of breast cancer cells
    1996
  32. Milčinski M; Clausen M; Weller R; Henze E
    Quantification of tricuspid regurgitation: hemodynamic impact on liver at time of gated ventriculography
    1992
  33. Milčinski M; Clausen M; Grossmann G; Weller R; Henze E
    Quantification of hemodynamic consequences of tricuspid regurgitation at the time of gated ventriculography
    1993
  34. Henze M; Milčinski M; Leitzenmayer R; Clausen M
    New aspects in nuclear cardiology - PET, NMR and SPECT
    1992
  35. Milčinski M; Henze E; Weller R; Clausen M; Adam WE; Porenta M
    Cardiac Sestamibi spect: inter- and intraobserver reproducibility
    1990
  36. Milčinski M; Henze E; Lietzenmayer R; Clausen M; Weller R; Hombach V; Adam WE; Porenta M
    Reproducibility of quantitative hexakis-2-methoxyisobutylisonitrile single photon emission tomography in stable coronary artery disease
    1991
  37. Pavlović S; Henze E; Clausen M; Adam WE; Kress P
    Inferoposterior myocardial wall defects using SPECT thallium-201 scintigraphy - artifacts or coronary artery disease
    1988


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics